The Current Ratio as of November 2024 (TTM) for Gritstone bio, Inc. (GRTS) is 2.54

According to Gritstone bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.54. This represents a change of -12.48% compared to the average of 2.90 of the last 4 quarters.

Gritstone bio, Inc. (GRTS) Historical Current Ratio (quarterly & annually)

How has GRTS Current Ratio performed in the past?

The mean historical Current Ratio of Gritstone bio, Inc. over the last ten years is 8.07. The current 2.54 Current Ratio has changed 3.05% with respect to the historical average. Over the past ten years (40 quarters), GRTS's Current Ratio was at its highest in in the June 2018 quarter at 12.90. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Gritstone bio, Inc. (GRTS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Gritstone bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gritstone bio, Inc. (GRTS) Average Current Ratio

How has GRTS Current Ratio performed in the past?

The current Current Ratio of Gritstone bio, Inc. (GRTS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Gritstone bio, Inc. (GRTS) Current Ratio vs. Peers

How is GRTS’s Current Ratio compared to its peers?

Gritstone bio, Inc.’s Current Ratio is less than Aurinia Pharmaceuticals Inc. (5.33), less than BridgeBio Pharma, Inc. (4.59), greater than Annovis Bio, Inc. (1.24), less than ImmunoGen, Inc. (5.47), less than Generation Bio Co. (7.42), less than Kronos Bio, Inc. (8.49), less than Erasca, Inc. (16.79), less than C4 Therapeutics, Inc. (6.31), less than Edgewise Therapeutics, Inc. (30.24), less than Kezar Life Sciences, Inc. (9.58), less than Fulcrum Therapeutics, Inc. (22.07), less than Passage Bio, Inc. (7.67), less than InflaRx N.V. (8.91), less than Allogene Therapeutics, Inc. (12.25), greater than G1 Therapeutics, Inc. (2.48), greater than Heron Therapeutics, Inc. (2.38), less than Annexon, Inc. (21.81), greater than Sangamo Therapeutics, Inc. (1.03), less than Affimed N.V. (2.71), less than Leap Therapeutics, Inc. (5.10), less than Adaptimmune Therapeutics plc (3.09), less than Corvus Pharmaceuticals, Inc. (3.62), greater than Aptose Biosciences Inc. (0.80),

Build a custom stock screener for Gritstone bio, Inc. (GRTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gritstone bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gritstone bio, Inc. (GRTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gritstone bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.